Jabs DA - Search Results

1

The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics.

Multicenter Uveitis Steroid Treatment Trial Research Group; Kempen JH, Altaweel MM, Holbrook JT, Jabs DA, Sugar EA. Multicenter Uveitis Steroid Treatment Trial Research Group, et al. Among authors: jabs da. Am J Ophthalmol. 2010 Apr;149(4):550-561.e10. doi: 10.1016/j.ajo.2009.11.019. Epub 2010 Jan 25. Am J Ophthalmol. 2010. PMID: 20097325 Free PMC article. Clinical Trial.

2

Measuring visual function and quality of life in patients with cytomegalovirus retinitis. Development of a questionnaire. Studies of Ocular Complication of AIDS Research Group.

Wu AW, Coleson LC, Holbrook J, Jabs DA. Wu AW, et al. Among authors: jabs da. Arch Ophthalmol. 1996 Jul;114(7):841-7. doi: 10.1001/archopht.1996.01100140055008. Arch Ophthalmol. 1996. PMID: 8660168 Clinical Trial.

3

Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy.

Nguyen QD, Kempen JH, Bolton SG, Dunn JP, Jabs DA. Nguyen QD, et al. Among authors: jabs da. Am J Ophthalmol. 2000 May;129(5):634-9. doi: 10.1016/s0002-9394(00)00356-1. Am J Ophthalmol. 2000. PMID: 10844056 Free article.

4

Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Studies of Ocular Complications of AIDS Research Group.

Holbrook JT, Davis MD, Hubbard LD, Martin BK, Holland GN, Jabs DA, Gilpin AK, Meinert C, Reshef DS. Holbrook JT, et al. Among authors: jabs da. Arch Ophthalmol. 2000 Sep;118(9):1196-204. doi: 10.1001/archopht.118.9.1196. Arch Ophthalmol. 2000. PMID: 10980764 Clinical Trial.

5

Episcleritis and scleritis: clinical features and treatment results.

Jabs DA, Mudun A, Dunn JP, Marsh MJ. Jabs DA, et al. Am J Ophthalmol. 2000 Oct;130(4):469-76. doi: 10.1016/s0002-9394(00)00710-8. Am J Ophthalmol. 2000. PMID: 11024419 Free article.

6

Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome.

Kempen JH, Jabs DA, Dunn JP, West SK, Tonascia J. Kempen JH, et al. Among authors: jabs da. Arch Ophthalmol. 2001 Jan;119(1):33-40. Arch Ophthalmol. 2001. PMID: 11146724

7

Patient notification and follow-up after suspension of treatment protocols. experience from four clinical trials of treatments for AIDS-related CMV retinitis.

Holbrook JT, Meinert CL, Jabs DA; Studies of Ocular Complications of AIDS Research Group. Holbrook JT, et al. Among authors: jabs da. Control Clin Trials. 2001 Feb;22(1):62-8. doi: 10.1016/s0197-2456(00)00112-4. Control Clin Trials. 2001. PMID: 11165425

8

Photographic measures of cytomegalovirus retinitis as surrogates for visual outcomes in treated patients.

Holbrook JT, Meinert CL, Van Natta ML, Davis M, Hubbard L, Jabs DA; Studies of Ocular Complications of AIDS Research Group. Holbrook JT, et al. Among authors: jabs da. Arch Ophthalmol. 2001 Apr;119(4):554-63. doi: 10.1001/archopht.119.4.554. Arch Ophthalmol. 2001. PMID: 11296021

9

Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy.

Jabs DA, Van Natta ML, Kempen JH, Reed Pavan P, Lim JI, Murphy RL, Hubbard LD. Jabs DA, et al. Am J Ophthalmol. 2002 Jan;133(1):48-61. doi: 10.1016/s0002-9394(01)01322-8. Am J Ophthalmol. 2002. PMID: 11755839

10

Incremental cost effectiveness of prophylaxis for cytomegalovirus disease in patients with AIDS.

Kempen JH, Frick KD, Jabs DA. Kempen JH, et al. Among authors: jabs da. Pharmacoeconomics. 2001;19(12):1199-208. doi: 10.2165/00019053-200119120-00002. Pharmacoeconomics. 2001. PMID: 11772155

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

349 results

Search Page

Filters